Skip to main content

Promising Research

The following studies are underway in the late stages of research. We're watching them closely.


April 11, 2022
BTK Inhibitors and Novel Approaches to Multiple Sclerosis 

October 20, 2020
Anti-inflammatory therapy shows promise in slowing progression of multiple sclerosis 

December 20, 2020
Researchers have identified an immune cell in mice that promotes axon regeneration and neuronal survival and could potentially be harnessed as a treatment for brain, spinal cord, and optic nerve damage.

January 19, 2021
Fatty acid may help combat multiple sclerosis

Regrowing Myelin

Fractalkine: a breakthrough for multiple sclerosis treatment?

Simple sugar possible therapy for repairing myelin in multiple sclerosis

Mechanisms identified to restore myelin sheaths after injury or in multiple sclerosis



Advances with Long Non-Coding RNAs in Diabetic Peripheral Neuropathy (A peer-reviewed study)

Kolon begins testing gene therapy for neuropathic pain in US

EicOsis EC5026 Granted Fast Track Designation by FDA for Neuropathic Pain

EC5026 just passed Phase 1a Clinical Trial, Nov 15, 2020: